Conceptually similarJuan GaertnerD-alanyl-D-lactate Ligase (VanA), Resistance to VancomycineSS22501031Rights ManagedJuan GaertnerBacterial Resistance to the Antibiotic VancomycinSS22501086Rights ManagedNano CreativeEnterococcus faecalis Bacteria, SEMSS21432642Rights ManagedNano CreativeEnterococcus faecalis Bacteria, SEMSS21432675Rights ManagedNano CreativeEnterococcus faecalis Bacteria, SEMSS21674575Rights ManagedSCIENCE PHOTO LIBRARYVancomycin antibiotic drug, molecular modelSS22002702Royalty FreeSCIENCE PHOTO LIBRARYVancomycin antibiotic drug, molecular modelSS22002703Royalty FreeSCIENCE PHOTO LIBRARYVancomycin antibiotic drug, molecular modelSS22002705Royalty FreeSCIENCE PHOTO LIBRARYVancomycin antibiotic drug, molecular modelSS22002706Royalty FreeView AllView more with similar tones Vancomycin Inhibits Cell Wall Synthesis of Gram-Positive BacteriaLicense type:Rights ManagedUnique identifier:SS22502359Description:The antibiotic vancomycin inhibits proper cell wall synthesis of gram-positive bacteria. Vancomycin, a tricyclic glycosylated peptide, binds to the peptide chains of the peptidoglycanes of the bacterial cell wall. Thus, the D-alanyl-D-lactate ligase (blue) cannot build up the bacterial wall, leading to the death of the bacteria. Source: PDB entry 1e4e.Credit:Juan Gaertner/Science Source / Science SourceSize:8000px × 6000px (~137 MB)Get PricingHow Will The Visual Be Used?ShareRelated Virtual folders:Explore Science Source ImagesKeywords:3d illustration-antibiotic-antibiotic resistance-bacteria-bacterial infection-bacterial wall-cell-cell wall-D-alanyl-D-lactate ligase-digital illustration-drug-enterococci-infection-microbiology-multidrug-resistant-multiresistance-pathogen-peptide-pharmacology-protein-public health-tricyclic-vancomycinFolder Legacy Identifier:SS2CT84082_20200203Model release:N/AParent folder:2020-02-03
